Butyzamide
Butyzamide is a novel, orally active small molecule thrombopoietin receptor (Mpl) agonist. It stimulates cellular proliferation and activates JAK/STAT and MAPK signaling pathways in vitro, and has demonstrated efficacy in elevating platelet counts in mouse xenotransplantation models.
Product Specifications
CAS Number
1110767-45-7
Product Name Alternative
Butyzamide, JAK, TPO, ThrombopoietinReceptor, Thrombopoietin Receptor
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Immunology & Inflammation, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.71% (May vary between batches)
Solubility
DMSO:165 mg/mL (278.93 mM)
Smiles
O (C) C1=C (C=CC=C1C (OCCC) C (C) (C) C) C=2N=C (NC (=O) C3=CC (Cl) =C (/C=C (/C (O) =O) \C) C (Cl) =C3) SC2
Molecular Formula
C29H32Cl2N2O5S
Molecular Weight
591.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
SARS-COV-2 Spike RBD Polyclonal Antibody (2019-nCoV)
SARS-COV-2 Spike RBD Polyclonal Antibody (2019-nCoV)
